LENSAR, Inc.

US$5.45As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LNSRHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (9.22%)
Div yield —
ROE 357.30%
Medical Devices
Beta (5Y) 1.03
PE TTM 10.27
TSR TTM (55.69%)
Mkt cap US$66.96M
ROIC (108.24%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.62
3.15%
(49.70%)
Hold 2|6|4|4|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.12
0.12
0.11
0.12
(1.61%)
0.56%
3.50%
3.19%
Revenue$M
3.520
3.500
3.545
3.670
7.33%
7.08%
8.87%
9.43%
Peers (US$66.96M)
Cap (US$)
PE
72.58M
—
65.37M
—
66.47M
9.594x
Capital
TTM
5Y
10Y
Leveragex
0.620
1.278
1.050
EBIT/Intx
0.998
2.361
2.053
Own earn%
7.91
(23.18)
(33.44)
Sh yield%
34.02
17.09
15.27
Owners
Insiders/Inst%
13.94
63.02
Short interest%
3.48
SBC / revenue%
3.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
23–33
$1 testx
—
Incr. ROIC%
6